TheEdgeResearch
Home / Stocks / KERN

Akerna Corp. (KERN)

NASDAQ Healthcare Medical - Healthcare Information Services
$0.31 ▲ +36.94%
Market Cap
$162,320
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Beta
2.79
52-Wk Range
0.25-20.4
CEO
Jessica Billingsley
Country
US
Currency
USD

Akerna Corp. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Denver, CO, US. The stock last traded at $0.31, up 36.94% on the session, giving a market capitalisation of $162,320. On trailing twelve-month figures it carries a trailing P/E of -0.36, a net margin of -68.3%. Its beta of 2.79 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.36
Price / Sales
0.00
Price / Book
0.03
EV / EBITDA
-6.15
Gross margin
52.5%
Operating margin
-80.2%
Net margin
-68.3%
Return on equity
Debt / equity
0.31
Current ratio
0.19
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
112
IPO date
2018-02-26
Headquarters
Denver, CO, US
About Akerna Corp.

Akerna Corp., a Denver, Colorado-based company established in 2010, develops and provides sophisticated enterprise software solutions. These solutions primarily cater to businesses in the United States and Canada, enabling robust regulatory compliance and efficient inventory management. Their product portfolio includes MJ Platform, specifically designed for the burgeoning cannabis, hemp, and CBD industries, and Leaf Data Systems, a dedicated regulatory software for government agencies. A cornerstone of their offerings is a comprehensive "seed-to-sale" platform. This technology furnishes cultivators, processors, retailers, and clinics within the cannabis sector with essential tools for tracking, reporting, and maintaining compliance throughout the entire supply chain, extending to what they term 'seed-to-sale-to-self' data. Akerna further extends its expertise through consulting services for the cannabis industry, alongside offerings in business intelligence, data analytics, and other software-related support. Additionally, they offer Last Call Analytics, a distinct tool that assists alcohol brands in scrutinizing their retail sales performance.

Comparable companies

Akerna Corp. is most often compared with the following Healthcare names:

ATLNBLPHCMAXHSTOHUGEMSPROTRKSEELTCBPVIRI
More research on KERN
KERN technical analysis KERN TheEdge Score Compare against peers
Open full interactive analysis & DCF →